News & Articles

Dr. Megan Allyse from the Mayo Clinic Center for Individualized Medicine explains why gene editing is not yet suitable for medical practice

Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research

University of Manchester's SYNBIOCHEM plan to use robotic automation to aid antibiotic discovery

First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies

Agilent expands SureGuide portfolio with new CRISPR-based transcriptional activation and interference (a/i) libraries

DESKGEN Series Libraries are designed and manufactured using the latest CRISPR gene editing techniques and artificial intelligence to deliver a tailored end-to-end solution

Registration is now open for our interactive webinar which will present the key benefits and applications of single-cell sequencing

New CRISPR screening services substantially broaden range of possible genetic studies

AMSBIO sponsor organoid technology training course

Cambridge scientists have uncovered genetic changes that result in a pre-cancerous stem cell population that can give rise to lymphoma

Catch-up on this week’s top Life Sciences content

Dr Maria Lopez deciphers microRNA regulation in pain perception. Read on to learn how she successfully uses multiple primary antibodies from the same host species.

Elucidating the roles of cancer associated fibroblasts in modulating the tumor microenvironment

Reduction of CRISPR off-target effects without significant loss of on-target activity

AriaDx provides modular solution for diagnostic labs and assay developers

Discover how a research group at the University of Geneva, Switzerland, is using an innovative approach to accelerate therapeutics through the drug development process